Virtus ETF Advisers LLC Acadia Pharmaceuticals Inc Transaction History

Virtus ETF Advisers LLC

$65.2 Million
Q2 2025

A detailed history of Virtus ETF Advisers LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 3,107 shares of ACAD stock, worth $65,060. This represents 0.1% of its overall portfolio holdings.

Number of Shares

3,107

Previous 3,107 -0.0%

Holding current value

$65,060

Previous $51,000 31.37%

% of portfolio

0.1%

Previous 0.07%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$16.61 - $20.29 $284,878 - $347,993	-17,151 Reduced 84.66%	3,107 $51,000
Q4 2024 Feb 14, 2025	SELL	$14.29 - $18.76 $22,406 - $29,415	-1,568 Reduced 7.18%	20,258 $371,000
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $120,571 - $151,909	8,247 Added 60.73%	21,826 $354,000
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $34,761 - $60,300	1,954 Added 16.81%	13,579 $251,000
Q4 2023 Feb 15, 2024	SELL	$20.78 - $31.77 $20,364 - $31,134	-980 Reduced 7.77%	11,625 $363,000
Q3 2023 Nov 07, 2023	SELL	$20.84 - $33.47 $33,969 - $54,556	-1,630 Reduced 11.45%	12,605 $262,000
Q2 2023 Aug 14, 2023	SELL	$17.8 - $25.65 $94,073 - $135,560	-5,285 Reduced 27.07%	14,235 $340,000
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $5,663 - $7,259	347 Added 1.81%	19,520 $367,000
Q4 2022 Feb 14, 2023	BUY	$14.2 - $18.63 $66,456 - $87,188	4,680 Added 32.29%	19,173 $305,000
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $3,005 - $3,891	213 Added 1.49%	14,493 $237,000
Q2 2022 Aug 12, 2022	SELL	$13.01 - $27.22 $24,614 - $51,500	-1,892 Reduced 11.7%	14,280 $201,000
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $10,292 - $16,606	-613 Reduced 3.65%	16,172 $377,000
Q3 2021 Nov 15, 2021	SELL	$15.78 - $24.77 $24,380 - $38,269	-1,545 Reduced 8.43%	16,785 $279,000
Q2 2021 Aug 10, 2021	BUY	$19.4 - $27.42 $122,724 - $173,458	6,326 Added 52.7%	18,330 $447,000
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $8,231 - $18,091	329 Added 2.82%	12,004 $310,000
Q4 2020 Feb 12, 2021	SELL	$41.04 - $56.79 $44,035 - $60,935	-1,073 Reduced 8.42%	11,675 $624,000
Q3 2020 Nov 13, 2020	BUY	$36.42 - $57.0 $39,115 - $61,218	1,074 Added 9.2%	12,748 $526,000
Q2 2020 Aug 05, 2020	SELL	$39.26 - $52.73 $62,894 - $84,473	-1,602 Reduced 12.07%	11,674 $566,000
Q1 2020 May 14, 2020	SELL	$31.65 - $46.87 $35,448 - $52,494	-1,120 Reduced 7.78%	13,276 $561,000
Q4 2019 Feb 13, 2020	SELL	$36.21 - $51.4 $512,987 - $728,183	-14,167 Reduced 49.6%	14,396 $616,000
Q3 2019 Nov 12, 2019	SELL	$22.22 - $44.01 $106,744 - $211,424	-4,804 Reduced 14.4%	28,563 $1.03 Million
Q2 2019 Aug 13, 2019	BUY	$23.32 - $28.12 $778,118 - $938,280	33,367 New	33,367 $892,000

Others Institutions Holding ACAD

# of Institutions

349

Shares Held

163M

Call Options Held

811K

Put Options Held

334K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Acadia Pharmaceuticals Inc Transaction History